nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2C19—urine—nephrolithiasis	0.0391	0.123	CbGeAlD
Ticlopidine—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0387	0.0566	CcSEcCtD
Ticlopidine—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0383	0.0561	CcSEcCtD
Ticlopidine—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0338	0.0494	CcSEcCtD
Ticlopidine—CYP1A2—urine—nephrolithiasis	0.032	0.101	CbGeAlD
Ticlopidine—CYP2C9—urine—nephrolithiasis	0.0303	0.0957	CbGeAlD
Ticlopidine—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0294	0.0431	CcSEcCtD
Ticlopidine—CYP2E1—urine—nephrolithiasis	0.0287	0.0907	CbGeAlD
Ticlopidine—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0265	0.0388	CcSEcCtD
Ticlopidine—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0234	0.0342	CcSEcCtD
Ticlopidine—CYP3A4—urine—nephrolithiasis	0.0231	0.073	CbGeAlD
Ticlopidine—CYP2D6—urine—nephrolithiasis	0.0228	0.0718	CbGeAlD
Ticlopidine—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0216	0.0316	CcSEcCtD
Ticlopidine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.021	0.0307	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0208	0.0304	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0199	0.0291	CcSEcCtD
Ticlopidine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0285	CcSEcCtD
Ticlopidine—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0276	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0275	CcSEcCtD
Ticlopidine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0254	CcSEcCtD
Ticlopidine—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0248	CcSEcCtD
Ticlopidine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0239	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0143	0.021	CcSEcCtD
Ticlopidine—MPO—renal system—nephrolithiasis	0.0143	0.0451	CbGeAlD
Ticlopidine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0208	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0208	CcSEcCtD
Ticlopidine—MPO—kidney—nephrolithiasis	0.0138	0.0436	CbGeAlD
Ticlopidine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0202	CcSEcCtD
Ticlopidine—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0136	0.02	CcSEcCtD
Ticlopidine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.013	0.019	CcSEcCtD
Ticlopidine—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0123	0.018	CcSEcCtD
Ticlopidine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0177	CcSEcCtD
Ticlopidine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0163	CcSEcCtD
Ticlopidine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0159	CcSEcCtD
Ticlopidine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0151	CcSEcCtD
Ticlopidine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00963	0.0141	CcSEcCtD
Ticlopidine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00963	0.0141	CcSEcCtD
Ticlopidine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00923	0.0135	CcSEcCtD
Ticlopidine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00904	0.0132	CcSEcCtD
Ticlopidine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0088	0.0129	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00841	0.0123	CcSEcCtD
Ticlopidine—CYP2C8—renal system—nephrolithiasis	0.00835	0.0264	CbGeAlD
Ticlopidine—CYP2B6—nephron tubule—nephrolithiasis	0.00824	0.026	CbGeAlD
Ticlopidine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00812	0.0119	CcSEcCtD
Ticlopidine—CYP2C8—kidney—nephrolithiasis	0.00808	0.0255	CbGeAlD
Ticlopidine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00802	0.0117	CcSEcCtD
Ticlopidine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00789	0.0116	CcSEcCtD
Ticlopidine—CYP1A2—renal system—nephrolithiasis	0.00782	0.0247	CbGeAlD
Ticlopidine—CYP2E1—nephron tubule—nephrolithiasis	0.00774	0.0244	CbGeAlD
Ticlopidine—CYP1A1—renal system—nephrolithiasis	0.00771	0.0243	CbGeAlD
Ticlopidine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00755	0.011	CcSEcCtD
Ticlopidine—CYP2B6—renal system—nephrolithiasis	0.00749	0.0237	CbGeAlD
Ticlopidine—CYP1A1—kidney—nephrolithiasis	0.00746	0.0235	CbGeAlD
Ticlopidine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00733	0.0107	CcSEcCtD
Ticlopidine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0073	0.0107	CcSEcCtD
Ticlopidine—CYP2B6—kidney—nephrolithiasis	0.00725	0.0229	CbGeAlD
Ticlopidine—CYP2E1—renal system—nephrolithiasis	0.00703	0.0222	CbGeAlD
Ticlopidine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0068	0.00995	CcSEcCtD
Ticlopidine—CYP2E1—kidney—nephrolithiasis	0.0068	0.0215	CbGeAlD
Ticlopidine—CYP2E1—cortex of kidney—nephrolithiasis	0.00662	0.0209	CbGeAlD
Ticlopidine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00969	CcSEcCtD
Ticlopidine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00653	0.00956	CcSEcCtD
Ticlopidine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00631	0.00924	CcSEcCtD
Ticlopidine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0061	0.00893	CcSEcCtD
Ticlopidine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00859	CcSEcCtD
Ticlopidine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00852	CcSEcCtD
Ticlopidine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00851	CcSEcCtD
Ticlopidine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00578	0.00846	CcSEcCtD
Ticlopidine—CYP3A4—renal system—nephrolithiasis	0.00566	0.0179	CbGeAlD
Ticlopidine—CYP2D6—renal system—nephrolithiasis	0.00557	0.0176	CbGeAlD
Ticlopidine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00802	CcSEcCtD
Ticlopidine—CYP3A4—kidney—nephrolithiasis	0.00547	0.0173	CbGeAlD
Ticlopidine—CYP2D6—kidney—nephrolithiasis	0.00538	0.017	CbGeAlD
